PNC Financial Services Group
PLRX icon

PNC Financial Services Group’s Pliant Therapeutics PLRX Stock Holding History

PNC Financial Services Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-978
Closed -$1.19K – 5283
2025
Q4 		$1.19K Sell
978
-6
-0.6% -$9 ﹤0.01% 4648
2025
Q3 		$1.46K Sell
984
-735
-43% -$1.12K ﹤0.01% 4583
2025
Q2 		$1.99K Sell
1,719
-921
-35% -$1.3K ﹤0.01% 4411
2025
Q1 		$3.56K Buy
2,640
+2,410
+1,048% +$14.6K ﹤0.01% 4172
2024
Q4 		$3.03K Buy
230
+167
+265% +$2.28K ﹤0.01% 4178
2024
Q3 		$706 Buy
63
+17
+37% +$213 ﹤0.01% 4515
2024
Q2 		$495 Sell
46
-1,739
-97% -$22.4K ﹤0.01% 4531
2024
Q1 		$26.6K Buy
1,785
+1,732
+3,268% +$28.6K ﹤0.01% 3293
2023
Q4 		$960 Buy
53
+31
+141% +$471 ﹤0.01% 4327
2023
Q3 		$381 Hold
22
– – ﹤0.01% 4489
2023
Q2 		$399 Sell
22
-169
-88% -$4K ﹤0.01% 4607
2023
Q1 		$5.08K Buy
+191
New +$5.44K ﹤0.01% 4038

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

PNC Financial Services Group's PLRX Position: Q1 2026 in Review

PNC Financial Services Group sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 978 shares — an estimated $1.19K sold.

PNC Financial Services Group first reported a position in PLRX in Q1 2023 and held it in 12 quarters. The position peaked at $26.6K in Q1 2024. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • PNC Financial Services Group reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 978 Pliant Therapeutics shares in Q1 2026, an estimated $1.19K.
  • PNC Financial Services Group first reported a position in Pliant Therapeutics in Q1 2023 and held it in 12 quarters.
  • PNC Financial Services Group's Pliant Therapeutics position peaked at $26.6K in Q1 2024.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.